Oncternal Therapeutics
ONCT | NASDAQ
$0.53
-$0.16 (-23.63%)
At close: Dec 02, 2024, 04:00 PM ET
Oncternal Therapeutics Statistics
Key statistics explainedMarket Data
$1.56M
$-12.83M
1.36
62.27K
2.96M
0.4%
N/A
NASDAQ
US68236P2065
Price Performance
N/A
N/A
N/A
N/A
N/A
-91.2%
-99.3%
-53.8%
-94.6%
-64.0%
-33.0%
Valuation
-0.05
N/A
-0.00
0.00
0.72
1.60
0.17
-0.06
-0.05
-0.05
-5.94
0.36
0.36
0.48
-2205.7%
-1708.8%
-2146.0%
Financial Health
$14.58M
$191K
$14.58M
$15.6M
6.94
6.94
0.01
-0.01
-0.01
-139.43
0.00
-24.98
2
Margins & Profitability
-3690.2%
-1664.0%
284.7%
-5029.2%
-1232.4%
-1547.7%
955.4%
-25.6%
Returns
-107.5%
61.6%
-131.6%
-132.3%
-107.5%
Historical Growth (CAGR)
-26.1%
0.0%
23.9%
-48.6%
-54.3%
15.0%
12.1%
-11.3%
-4.3%
Analyst Forecasts
Buy
7
N/A
N/A
Nov 6, 2024
-$3.22
-5.3%
$275K
53.6%
Fair Value Estimates
N/A
N/A
N/A
N/A
$28.00
5183.0%
Cash Flow
$-26.63M
$-26.63M
$-33.45M
-$10.94
-$10.94
-4097.3%
Income Statement
$2.16M
$-22.22M
$-35.96M
$-35.52M
$-34.58M
-$11.69
$80.04K
$-1.28M
27
Add to Watchlist
Select watchlists to add or remove ONCT